Skip to main content
Clinical Trials/NCT02441595
NCT02441595
Completed
N/A

Mindfulness Based Childbirth and Parenting Education - RCT of Effects on Parent and Child Health

Karolinska Institutet0 sites193 target enrollmentJanuary 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parent-Child Relations
Sponsor
Karolinska Institutet
Enrollment
193
Primary Endpoint
Change in Perceived Stress Scale 14-item
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to explore if an intervention using Mindfulness Based Childbirth and Parenting education (MBCP) targeted to stressed pregnant women is effective in: 1) reducing prenatal stress, 2) preventing perinatal maternal mental ill-health, 3) preparing the mother for labor and 4) promoting positive infant-caregiver attachment.

Detailed Description

Sample: Pregnant women experiencing high levels of stress, and/or who previously have had periods of depression or anxiety, and/or who have had some childhood neglect, will be eligible for the study. A sample of 170 mothers and their partners recruited from antenatal clinics in Stockholm will be asked to participate. The participants in the study will be randomized to either treatment or control intervention. The study uses an experimental design with assessments at baseline and post-intervention as well as follow-ups at 3, 9 and 15 months post-partum. The intervention involves eight 2.5 h weekly group sessions in which exercises in mindfulness are practiced and associated theory is taught to increase metacognition, emotional regulation and body awareness. Participants in the control condition are being offered a standardized course in psychoprophylaxis. Measurements - parental outcomes PSYCHOLOGICAL FUNCTIONING - 10 item Perceived Stress Scale \[10\]. Edinburgh Postnatal Depression Scale \[11\]. Positive States of Minds \[12\]. INTERVENTION ADHERENCE - Questions to assess intervention adherence. PHYSIOLOGICAL ASSESSMENTS - Heart Rate Variability (HRV) will be examined through ECG. The investigators hypothesize that the intervention will increase HRV in the pregnant women, thus providing an objective measure of stress. The investigators will test if women who receive the intervention during pregnancy have lower serum levels of the cytokines interleukin-6 and interleukin-10, Brain Derived Neurotrophic Factor-s, and Corticotrophin Releasing Hormone compared to the control group - physiological components that influence the fetus and are associated with immune response, hypothalamic-pituitary-adrenal axis functions, stress-related mood disorders and preterm delivery \[13-16\]. LABOUR - Labour records will be gathered from all participants. Measurements - infants PHYSIOLOGICAL ASSESSMENTS - Heart Rate Variability (HRV) examined through ECG at 15 months of age. The investigators hypothesize that increased maternal HRV in the pregnancy will be associated with increased infant HRV. The investigators will also test if infants whose mothers have received the intervention have lower serum levels of the cytokines interleukin-6 and interleukin-10, Brain Derived Neurotrophic Factor-S, and Corticotrophin Releasing Hor-mone: Levels will be analyzed from PKU blood spots, routinely collected 3-4 days after birth. INFANT SOCIAL AND EMOTIONAL FUNCTIONING - The attachment style of the infants will be assessed at age 15 months, using the standard Parent-Child Early Relational Assessment developed by Clark \[17\]. Data analysis: Appropriate methods will be applied to describe the sample. Hypothesis will be tested by multivariate repeated measures analysis of covariance (MANCOVA) with perceived stress as the primary outcome.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
August 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gunilla Lönnberg

M PH

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • The study is open to pregnant women in the late second or early third trimester of pregnancy who are screened with a short questionnaire: Those who report high levels of perceived stress, and/or previous mental health issues such as depression/anxiety, and/or childhood neglect are included. Participants must also speak fluent Swedish.

Exclusion Criteria

  • Actively psychotic, having previous experience of mindfulness, third wave cognitive behavioral therapies, or related practices.

Outcomes

Primary Outcomes

Change in Perceived Stress Scale 14-item

Time Frame: From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old

A scale measuring perception of stressful experiences during the past month

Parent Child Early Relational Assessment

Time Frame: When infant is 12 months old

Measures infant and primary caregiver attachment

Secondary Outcomes

  • Change in Maternal serum levels of Brain Derived Neurotrophic Factor-s(from baseline to 9 weeks (post-intervention))
  • Pregnancy Interveiw(Baseline measure)
  • Change in Maternal heart rate variability(from baseline to 9 weeks (post-intervention))
  • Infant Heart Rate Variability(At age 12 months)
  • Change in Maternal serum levels of cytokines interleukin-6 and interleukin-10(from baseline to 9 weeks (post-intervention))
  • Change in Maternal serum levels of Corticotrophin Releasing Hormone(from baseline to 9 weeks (post-intervention))
  • Change in Five Facets of Mindfulness(From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old)
  • Infant serum levels of Brain Derived Neurotrophic Factor-S(At age 2-3 days)
  • Change in Edinburgh Postnatal Depression Scale(From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old)
  • Change in Positive States of Minds(From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old)
  • Infant serum levels of the cytokines interleukin-6 and interleukin-10(At age 2-3 days)
  • Infant serum levels of Corticotrophin Releasing Hormone(At age 2-3 days)
  • Labour records(1 week after giving birth)

Similar Trials